학술논문

FDA Approval Summary: Belzutifan for von Hippel-Lindau Disease–Associated Tumors
Document Type
Article
Source
In: Clinical Cancer Research. (Clinical Cancer Research, 15 November 2022, 28(22):4843-4848)
Subject
Language
English
ISSN
15573265
10780432